Flutoprazepam

氟托西泮

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameFlutoprazepam
Drug Alias NameRestasKB-509
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGamma-aminobutyric acid A receptor agonists
TargetsGamma-aminobutyric acid A receptor
Therapy Area/IndicationsAnxietyDepressionSleep Wake Disorders
Global Approved IndicationsAnxietyDepressionSleep Wake Disorders
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date1986/04/30
Country/TerritoryJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesNihon Generic
China Registration ClassN/A

Develop Information

Active CompaniesNihon Generic
Inactive CompaniesN/A
Active IndicationsAnxietyDepressionSleep Wake Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN03AEN05BAN05CD
Related LinksWikipediaKEGG